Your browser is no longer supported. Please, upgrade your browser.
Settings
MDVN Medivation, Inc. daily Stock Chart
MDVN [NASD]
Medivation, Inc.
Index- P/E42.40 EPS (ttm)1.43 Insider Own1.10% Shs Outstand165.09M Perf Week0.12%
Market Cap10.01B Forward P/E28.37 EPS next Y2.14 Insider Trans-5.33% Shs Float162.64M Perf Month7.94%
Income252.70M PEG1.19 EPS next Q0.32 Inst Own92.80% Short Float2.15% Perf Quarter69.50%
Sales996.60M P/S10.04 EPS this Y-11.10% Inst Trans-0.46% Short Ratio0.91 Perf Half Y47.27%
Book/sh5.48 P/B11.06 EPS next Y62.63% ROA21.50% Target Price62.59 Perf Year-8.17%
Cash/sh- P/C- EPS next 5Y35.64% ROE34.00% 52W Range26.41 - 66.39 Perf YTD25.42%
Dividend- P/FCF33.30 EPS past 5Y50.90% ROI27.10% 52W High-8.68% Beta0.92
Dividend %- Quick Ratio4.20 Sales past 5Y72.10% Gross Margin- 52W Low129.57% ATR1.64
Employees628 Current Ratio4.20 Sales Q/Q41.30% Oper. Margin40.20% RSI (14)61.68 Volatility2.34% 2.67%
OptionableYes Debt/Eq0.00 EPS Q/Q243.60% Profit Margin25.40% Rel Volume0.78 Prev Close60.31
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout0.00% Avg Volume3.85M Price60.63
Recom2.10 SMA200.36% SMA5017.03% SMA20037.94% Volume3,009,021 Change0.53%
May-06-16Upgrade Citigroup Neutral → Buy
May-06-16Reiterated Barclays Overweight $48 → $70
May-05-16Reiterated Maxim Group Buy $47 → $76
May-02-16Reiterated Stifel Buy $52 → $66
May-02-16Reiterated Jefferies Hold $39 → $52
Apr-29-16Reiterated Wedbush Outperform $47 → $59
Apr-06-16Initiated Sun Trust Rbsn Humphrey Buy $56
Mar-31-16Reiterated Credit Suisse Outperform $48 → $49
Mar-30-16Initiated Goldman Neutral
Feb-19-16Initiated BofA/Merrill Buy
Feb-01-16Reiterated Wedbush Outperform $59 → $47
Jan-27-16Downgrade Canaccord Genuity Buy → Hold $90 → $45
Jan-21-16Initiated Credit Suisse Outperform
Nov-10-15Reiterated Maxim Group Buy $74 → $54
Nov-09-15Reiterated RBC Capital Mkts Sector Perform $50 → $40
Nov-06-15Reiterated UBS Buy $74 → $68
Nov-06-15Reiterated RBC Capital Mkts Sector Perform $50 → $40
Sep-28-15Reiterated Maxim Group Buy $171 → $74
Sep-16-15Initiated Nomura Buy
Sep-03-15Initiated Citigroup Neutral
May-28-16 12:15AM  [$$] Medivations Sanofi Strategy May Be in Trouble at The Wall Street Journal
May-27-16 08:05PM  [$$] Medivation May Feel Pressured by Sanofi at The Wall Street Journal
04:28PM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:20PM  Dealpolitik: Medivation's 'Just Say No' Strategy May Be in Trouble at The Wall Street Journal
11:46AM  Medivation Fires Back Following Sanofi's Board Proposal
10:01AM  Interested in Medivation? Take a Number! at Motley Fool
08:33AM  Delayed FDA Decision Sends Sarepta Therapeutics Soaring
08:08AM  Medivation Files Preliminary Consent Revocation Statement Business Wire
May-26-16 01:38PM  Could Rally Cool Off Ahead Of Friday's GDP Data and Yellen Speech?
11:35AM  How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi at 24/7 Wall St.
10:34AM  Please Gilead, Celgene and Amgen. Don't Buy Medivation. at Barrons.com
10:23AM  5 stocks to watch at MarketWatch
10:20AM  Sanofi's Diabetes Drug Combination Wins FDA Panel Backing
02:25AM  PRESS DIGEST- New York Times business news - May 26 Reuters
12:12AM  [$$] Sanofi Moves to Replace Medivation Board at The Wall Street Journal
May-25-16 05:39PM  Sanofi Just Went Hostile in Its Medivation Takeover Bid at Fortune
04:59PM  Medivation: Three Biotech Giants Enter. Which One Leaves? at Barrons.com
04:33PM  Sanofi moves to oust Medivation board in $9.3 bln takeover fight Reuters
04:16PM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:10PM  Medivation to Present at the Following Conferences Marketwired
04:08PM  Sanofi Moves To Replace Medivations Board As New Buyers Rumored
01:59PM  [$$] Sanofi Moves to Replace Medivation Board at The Wall Street Journal
01:17PM  Heres Why Medivation Inc (MDVN) Is in Spotlight Today at Insider Monkey
01:07PM  [$$] Sanofi seeks to oust entire Medivation board at Financial Times
12:38PM  Why Sanofi SA (ADR) (SNY) Is Trending on Wednesday at Insider Monkey
12:23PM  European Markets End in Positive Territory; Rally for Second Day
12:02PM  Sanofi Plays Game of Chicken With Medivation at Bloomberg
11:31AM  Pfizer Wants to Be Seen as an Oncology Powerhouse
11:00AM  Sanofi wants to dump Medivation's board after rejected deal
10:48AM  Medivation Advises Its Shareholders To Spurn Sanofi's Move To Replace Entire Board
10:24AM  Sanofi Moves to Oust Medivation Board
09:28AM  The Market In 5 Minutes: Bold Moves
08:46AM  Medivation Urges Stockholders to Reject Sanofis Attempt to Replace Medivation Board of Directors Business Wire
08:23AM  Celgene, Gilead Said to Join Suitors Mulling Medivation Bids at Bloomberg
07:19AM  Sanofi Seeks to Change Medivation Board as Advances Spurned at Bloomberg
06:58AM  Sanofi names eight candidates to replace Medivation board
06:01AM  May 25 Premarket Briefing: 10 Things You Should Know
12:37AM  Exclusive: Sanofi to unveil challenge to Medivation's board - sources
May-23-16 07:00AM  Arm of I-SPY 2 TRIAL Investigating Medivation's Talazoparib for Treatment of Breast Cancer Activated Marketwired
May-21-16 09:40AM  Here's What Pfizer's Telling Us About Biotech M&A at Motley Fool
May-20-16 12:07PM  A Scarcity of Biotech Assets for Buyouts? at Barrons.com
09:30AM  The Zacks Analyst Blog Highlights: Medivation, Anacor, Aduro, Trevena and Tetraphase
May-19-16 03:36PM  Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, Trevena
May-17-16 03:06PM  Medivation: Xtandi Global Sales Rose 53% in 1Q16
08:13AM  Pfizer to Buy Anacor, Add Eczema Treatment to Portfolio Zacks
06:07AM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-16-16 01:05PM  Pfizer to buy Peninsula drug developer for $5.2 billion in latest Bay Area M&A at American City Business Journals
11:57AM  Pfizer Beats Allergan to Eczema Drugmaker Anacor for $5.2B at TheStreet
10:06AM  What Do Analysts Recommend for Medivation?
May-13-16 06:07PM  Medivation Is for Sale: How Much Should It Get?
05:46PM  Medivation Shares Stand Pat Amid Further Bid Speculation at TheStreet
05:06PM  Sanofi Is Moving to Replace Medivations Entire Board in Takeover Bid at Fortune
11:55AM  Sanofi presses on with threat to oust Medivation's board
10:45AM  Sanofi Said to Nominate Slate to Replace Medivation Board at Bloomberg
09:30AM  The Zacks Analyst Blog Highlights: Medivation, Juno, Kite, ARIAD and AbbVie Zacks
09:20AM  Sanofi to nominate 8 people to replace Medivation board CNBC
May-12-16 12:07PM  Biotech Stock Roundup: Medivation Buyout Rumors Continue, NewLink Plunges on Late-Stage Data Zacks
09:35AM  Will the Current Pipeline Help Medivation Go beyond Xtandi? Market Realist
09:35AM  Analyzing Medivations Growth Opportunity with Xtandi Market Realist
06:08AM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
May-11-16 01:04PM  MEDIVATION, INC. Financials EDGAR Online Financials
11:14AM  Global Pharma Players Likely to Flock to Medivation at TheStreet
09:09AM  The Story behind Medivations Rising Collaboration Revenue Market Realist
07:35AM  Medivation Receives Prestigious Award From American Urological Association (AUA) Marketwired
May-10-16 07:08PM  Medivations Market Cap Reaches $10 Billion: Bidders Line Up Market Realist
04:13PM  Why Did Medivations Share Price Increase so Much after Earnings? Market Realist
04:13PM  Why Did Medivations 1Q16 Earnings Disappoint? Market Realist
06:03AM  May 10 Premarket Briefing: 10 Things You Should Know at TheStreet
May-09-16 05:52PM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:32PM  Medivation Reportedly Yielding To Buyer Interest; Stock Surges at Investor's Business Daily
02:15PM  Exclusive: Medivation succumbs to pressure to explore sale -sources Reuters
02:00PM  Medivation (MDVN) Stock Surges, Will Explore Sale at TheStreet
01:59PM  This cancer drugmaker is reportedly exploring a sale and the stock is jumping Business Insider
11:09AM  Medivation, Inc. :MDVN-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
08:08AM  Analysts' Actions -- Fidelity, Medivation, Occidental, Paccar and More TheStreet
May-07-16 12:30PM  Analysts Adjust Predictions on Medivation Buyout Price at 24/7 Wall St.
08:30AM  This Is Why Biotech Stocks May Explode Again at Investor's Business Daily
May-06-16 02:40PM  Medivation appeals to its 'great teams' of employees in Sanofi saga. But how long can it repel buyer? at American City Business Journals
01:01PM  2 Longs and 2 Shorts to Watch in the Stock Market at TheStreet
12:03PM  Why These Five Stocks Are Trending Today? at Insider Monkey
10:41AM  Medivation: Better On Its Own? at Barrons.com
09:46AM  Faber Report: Medivation reiterates rejection CNBC
08:04AM  Medivation Takeover Talk: Sanofi May Lose Out Despite Offer To Raise Bid Yahoo Finance Contributors
07:55AM  Early movers: CI, ICE, SQ, ATVI, YELP, HON, WYNN, GPRO, HLF & more at CNBC
07:26AM  Sanofi's Medivation Bear Hug Lacks Muscle at Bloomberg
07:21AM  Medivation upgraded by Citigroup Briefing.com
06:34AM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:46AM  Edited Transcript of MDVN earnings conference call or presentation 5-May-16 8:30pm GMT Thomson Reuters StreetEvents
12:41AM  PRESS DIGEST - Wall Street Journal - May 6 Reuters
12:07AM  [$$] Sanofi Says It Will Try to Oust Medivation Board Members if Deal Talks Dont Start at The Wall Street Journal
May-05-16 07:41PM  Sanofi ready to up offer for drugmaker Medivation, could oust board Reuters
07:36PM  [$$] Sanofi: Will Try to Oust Medivation Board Unless Deal Talks Start at The Wall Street Journal
05:01PM  Medivation Misses Q1 Estimates As Sanofi Turns Up The Buyout Heat at Investor's Business Daily
04:58PM  As Sanofi hints at higher takeover price, Medivation holds its ground at American City Business Journals
04:48PM  Medivation: And Then There Were Five at Barrons.com
04:31PM  MEDIVATION, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statement EDGAR Online
04:30PM  Medivation Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:10PM  Medivation Reports First Quarter 2016 Financial Results Marketwired
03:47PM  Bullish On Cynosure And Medivation, Bearish On Eagle Pharma And Royal Caribbean at Forbes
01:21PM  Medivation Reiterates Rejection Of Sanofi's Inadequate Proposal To Buy It Benzinga
Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of medical therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (CRPC) patients. The company also develops Enzalutamide, which is in phase III clinical trials for the treatment of non-metastatic CRPC, and metastatic and non-metastatic hormone sensitive prostate cancer; and phase II clinical trials for the treatment of hepatocellular carcinoma, androgen receptor positive (AR+) triple negative breast cancer, estrogen receptor positive or progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) normal breast cancer, and AR+ HER2 amplified breast cancer. In addition, it develops Talazoparib, which is in phase II clinical trials for treatment of germline mutated HER2 normal breast cancer; Pidilizumab that is in phase II clinical trials for the treatment of relapsed or refractory diffuse large B-cell lymphoma; and MDV4463, which is in phase I clinical trials for the treatment of nonalcoholic steatohepatitis. The company has collaboration agreement with Astellas Pharma, Inc. for the development, manufacture, and commercialization of XTANDI; and License and Manufacturing and supply agreement with CureTech, Ltd. for the development, manufacture, and commercialization of biologic molecules. Medivation, Inc. is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bierly RickCFO (former)May 06Sale60.126,315379,63728,744May 09 05:35 PM
Bierly RickCFO (former)May 05Sale59.204,025238,28035,059May 09 05:35 PM
Svoronos DawnDirectorMar 14Sale38.906,000233,40018,234Mar 16 05:06 PM
Hirmand MohammadInterim Chief Medical OfficerMar 04Sale41.101,52562,68539,342Mar 07 08:44 PM
Bierly RickChief Financial OfficerMar 04Sale40.002,998119,92039,084Mar 07 08:43 PM
Hung DavidPresident and CEOFeb 04Sale31.186,350197,9931,504,654Feb 05 07:05 PM
Machado Clarence PatrickDirectorJan 19Option Exercise3.3775,000252,525141,156Jan 21 05:45 PM
Machado Clarence PatrickDirectorJan 19Sale37.3475,0002,800,56266,156Jan 21 05:45 PM
Lobacki Joseph MChief Commercial OfficerJan 04Sale46.503,065142,52319,365Jan 05 06:14 PM
VERNON W ANTHONYDirectorDec 14Buy40.6915,000610,35028,704Dec 16 05:40 PM
Hung DavidPresident and CEODec 03Sale43.1010,950471,9661,511,004Dec 04 04:36 PM
Hirmand MohammadInterim Chief Medical OfficerDec 03Sale43.401,07546,65531,113Dec 04 04:35 PM
Hirmand MohammadInterim Chief Medical OfficerNov 09Sale41.912329,72232,188Nov 12 06:46 PM
Svoronos DawnDirectorSep 08Sale89.153,100276,36512,117Sep 08 07:39 PM
Machado Clarence PatrickDirectorJun 04Option Exercise9.3936,000337,86067,500Jun 08 06:25 PM
Machado Clarence PatrickDirectorJun 04Sale117.4336,0004,227,47831,500Jun 08 06:25 PM